Gonadorelin (GnRH) is a ten-amino acid peptide and a potent agonist of gonadotropin-releasing hormone. Its main function is to stimulate the synthesis and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In human medicine, it finds application in treating infertility, menstrual cycle irregularities, and hypogonadism. Additionally, it serves as a valuable diagnostic tool for assessing pituitary function.
Exciting ongoing research has uncovered promising potential uses for gonadorelin in the treatment of breast and prostate cancer, as well as in addressing Alzheimer’s disease. These findings open up new possibilities for the therapeutic application of gonadorelin in diverse medical contexts.
Sequence: Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
Molecular Formula: C55H75N17O13
Molecular Weight: 1182.311 g/mol
PubChem CID: 638793
CAS Number: 9034-40-6
Synonyms: Growth Hormone Releasing Factor, Somatocrinin, Somatoliberin
WhatsApp+8617367732028
jintropin | hygetropin | AOD9604 | Hcg | HGH fragment | CJC-1295 |
TB-500 | BPC-157 | PT-141 | Retatrutide | semaglutide | Tirzepatide |
CHRP-2 | CHRP-6 | Melanotanll | peg-mgf | oxytocin | lpamorelin |
MGF | DSIP | Sermorelin | Hexarelin | Gonadorelin | Selank |
Epithalon | Tesamorelin | Triptorelin | igf lr3 | follistin 344 | GHK-CU |
dihexa | adipotide | Kisspeptin | semax | MOTS-C | NAD |